FDA Approves New Hot Flash Treatment for Menopause

There are other drugs to treat the condition

   

11927463 prescription medicine spilling from open bottles 300x142 FDA Approves New Hot Flash Treatment for MenopauseWomen who experience strong physical effects associated with menopause will have a new drug to treat the symptoms early next year.

The U.S. Food and Drug Administration has given the green light for Duavee, a drug made by Pfizer (PFE) and Ligand Pharmaceuticals (LGND), to hit the market. The treatment is designed to mitigate moderate-to-severe menopausal hot flashes in women who have not undergone a hysterectomy, Bloomberg notes.

NovartisLogo e1284400876411 FDA Approves New Hot Flash Treatment for Menopause
Authorities to Raid Novartis Offices Over Fake Drug Data

Duavee, which will is expected to reach consumers in the first quarter of 2014, also protects bone density in post-menopausal women. Nausea, diarrhea, abdominal pain and muscle spasms are among the side effects attributed to the drug.

A number of other treatments already exist to combat the effects of hot flashes, including Evista from Eli Lilly (LLY) and Brisdelle from Hisamitsu Pharmaceutical. Evista accounted for $1 billion in sales last year.

Shares of Pfizer dipped slightly in Friday morning trading, while Ligand Pharmaceutical rose modestly.


Article printed from InvestorPlace Media, http://investorplace.com/2013/10/fda-approves-new-hot-flash-treatment-for-menopause/.

©2014 InvestorPlace Media, LLC

Comments are currently unavailable. Please check back soon.